AI Terminal
ITACONIX PLC
Board/Management Information • Jan 26, 2024
7720_rns_2024-01-26_d0b28f7c-f6b6-45ee-bf5c-1b172394ea77.html
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9812A
Itaconix PLC
26 January 2024
Itaconix plc
("Itaconix" or the "Company")
Appointment of Nominated Adviser and Sole Broker
Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, is pleased to announce that it has appointed Canaccord Genuity Limited as its Nominated Advisor and Sole Broker, with immediate effect.
In addition to the disclosures made in Paul LeBlanc's appointment announcement on 5 January 2023, the following current directorships are disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:
| Company | Supporting Information |
| Safe Reflections International Holdings LLC | A subsidiary of Bemis Associates Inc. directorship held at the time of appointment to Itaconix |
| Protechnic S.A. | A subsidiary of Bemis Associates Inc. directorship held at the time of appointment to Itaconix |
| Itaconix plc | +1 603 775-4400 |
| John R. Shaw / Laura Denner | |
| Belvedere Communications | +44 (0)20 7653 8702 |
| John West / Llew Angus | |
| Canaccord Genuity - Nominated Adviser and Sole Broker Adam James / Harry Pardoe |
+44 (0) 20 7523 8000 |
About Itaconix
Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPPPUUPGUPCPUA